Skip to main content
. Author manuscript; available in PMC: 2008 Oct 6.
Published in final edited form as: Psychopharmacology (Berl). 2008 May 29;199(4):637–650. doi: 10.1007/s00213-008-1183-y

Figure 7.

Figure 7

CWM performance beginning 2 weeks following MA treatment. The main effect of Treatment is shown in A, C, E and all 4 treatment groups are displayed in B, D, F. MA-treated animals, regardless of regimen, demonstrated increased latencies beginning on day 5 (A, B), increased number of errors beginning on day 5 (C, D), and increased returns to start beginning on day 4 (E, F). (SAL-120min n = 19, MA-120min n = 19, SAL-15min n = 20, MA-15min n = 20). *p ≤ 0.05 MA vs SAL, regardless of regimen.